Prescription drug · ANDA
Clindamycin (Clindamycin phosphate) NDC 25021-115
Clindamycin phosphate 150 mg/mL · Injection, Solution · Intramuscular, Intravenous · Sagent Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25021-115-02 | 2502101150225021011502 | 25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIALMarketed from May 15, 2012 | |
| 25021-115-04 | 2502101150425021011504 | 25 VIAL in 1 CARTON (25021-115-04) / 4 mL in 1 VIALMarketed from May 15, 2012 | |
| 25021-115-06 | 2502101150625021011506 | 25 VIAL in 1 CARTON (25021-115-06) / 6 mL in 1 VIALMarketed from May 15, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clindamycin
- Generic name (nonproprietary)
- clindamycin phosphate
- Active ingredients
- Clindamycin phosphate — 150 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- Sagent PharmaceuticalsNDC labeler code 25021
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090108
- Marketing start
- Marketing end
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
- Identifiers
- Product ID 25021-115_ca8ce6e9-feae-4a33-a380-64061313d704SPL ID ca8ce6e9-feae-4a33-a380-64061313d704
- Pharmacologic class
- Lincosamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N425021011502followed by a unit qualifier and the quantityPackage 25021-0115-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 25021-115
- What is NDC 25021-115?
- 25021-115 is the product NDC for Clindamycin (clindamycin phosphate), Clindamycin phosphate 150 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Clindamycin (Clindamycin Phosphate).
- What is the active ingredient?
- Clindamycin phosphate.
- Who is the labeler?
- Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Clindamycin?
- 5 other product NDCs are listed under this name. See all Clindamycin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Clindamycin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Henry Schein, Inc. | 0404-9838 | 00404-9838-04 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7191 | 71872-7191-01 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7192 | 71872-7192-01 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntravenous | Medical Purchasing Solutions, LLC | 71872-7199 | 71872-7199-01 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7284 | 71872-7284-01 |
Other NDCs under ANDA 090108
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Henry Schein, Inc. | 0404-9838 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7191 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7192 |
| Clindamycinclindamycin phosphate | Clindamycin phosphate 150 mg/mL | Injection, SolutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7284 |